Growth Metrics

Acadia Pharmaceuticals (ACAD) Enterprise Value Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Acadia Pharmaceuticals 3.69 Bn 2.84 Bn 243.27 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -28.33%
Dec 31, 2025 -25.28%
Sep 30, 2025 -24.72%
Jun 30, 2025 -20.42%
Mar 31, 2025 -15.19%
Dec 31, 2024 -13.23%
Sep 30, 2024 -1.52%
Jun 30, 2024 3.47%
Mar 31, 2024 6.62%
Dec 31, 2023 11.44%
Sep 30, 2023 18.73%
Jun 30, 2023 17.09%
Mar 31, 2023 14.80%
Dec 31, 2022 15.77%
Sep 30, 2022 13.89%
Jun 30, 2022 -4.54%
Mar 31, 2022 -2.48%
Dec 31, 2021 -3.22%
Sep 30, 2021 -36.14%
Jun 30, 2021 -29.43%
Mar 31, 2021 -24.69%
Dec 31, 2020 -22.79%
Sep 30, 2020 -20.69%
Jun 30, 2020 -16.42%
Mar 31, 2020 -11.54%
Dec 31, 2019 -9.65%
Sep 30, 2019 -5.11%
Jun 30, 2019 2.54%
Mar 31, 2019 3.23%
Dec 31, 2018 -30.08%
Sep 30, 2018 3.82%
Jun 30, 2018 1.74%
Mar 31, 2018 -0.02%
Dec 31, 2017 -1.91%
Sep 30, 2017 -2.77%
Jun 30, 2017 -5.59%
Mar 31, 2017 -8.33%
Dec 31, 2016 -41.74%
Sep 30, 2016 -46.96%
Jun 30, 2016 -30.00%
Mar 31, 2016 -76.05%
Dec 31, 2015 -33.55%
Sep 30, 2015 -118.55%
Jun 30, 2015 -133.21%
Mar 31, 2015 -125.66%
Dec 31, 2014 -118.19%
Sep 30, 2014 -110.63%
Jun 30, 2014 -106.32%
Mar 31, 2014 -278.15%
Dec 31, 2013 -71.11%
Sep 30, 2013 -167.83%